Swiss National Bank’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Hold |
186,500
| – | – | ﹤0.01% | 1768 |
|
|
2025
Q1 | $1.63M | Sell |
186,500
-1,900
| -1% | -$16.6K | ﹤0.01% | 1885 |
|
|
2024
Q4 | $2.71M | Buy |
188,400
+2,700
| +1% | +$38.8K | ﹤0.01% | 1683 |
|
|
2024
Q3 | $4.19M | Sell |
185,700
-1,400
| -0.7% | -$31.6K | ﹤0.01% | 1436 |
|
|
2024
Q2 | $3.64M | Buy |
187,100
+12,400
| +7% | +$241K | ﹤0.01% | 1466 |
|
|
2024
Q1 | $6.56M | Buy |
174,700
+1,500
| +0.9% | +$56.3K | ﹤0.01% | 1126 |
|
|
2023
Q4 | $9.69M | Sell |
173,200
-10,200
| -6% | -$571K | 0.01% | 905 |
|
|
2023
Q3 | $7.57M | Sell |
183,400
-6,900
| -4% | -$285K | 0.01% | 1036 |
|
|
2023
Q2 | $10.6M | Buy |
190,300
+25,200
| +15% | +$1.41M | 0.01% | 875 |
|
|
2023
Q1 | $9.21M | Sell |
165,100
-18,500
| -10% | -$1.03M | 0.01% | 918 |
|
|
2022
Q4 | $6.69M | Sell |
183,600
-16,900
| -8% | -$616K | ﹤0.01% | 1133 |
|
|
2022
Q3 | $5.71M | Buy |
200,500
+2,500
| +1% | +$71.2K | ﹤0.01% | 1198 |
|
|
2022
Q2 | $8.96M | Sell |
198,000
-139,224
| -41% | -$6.3M | 0.01% | 977 |
|
|
2022
Q1 | $25.7M | Buy |
337,224
+44,600
| +15% | +$3.39M | 0.01% | 630 |
|
|
2021
Q4 | $43.6M | Sell |
292,624
-600
| -0.2% | -$89.4K | 0.03% | 531 |
|
|
2021
Q3 | $42.7M | Sell |
293,224
-5,100
| -2% | -$742K | 0.03% | 530 |
|
|
2021
Q2 | $58.4M | Buy |
298,324
+51,724
| +21% | +$10.1M | 0.04% | 463 |
|
|
2021
Q1 | $44.6M | Buy |
246,600
+14,700
| +6% | +$2.66M | 0.03% | 521 |
|
|
2020
Q4 | $32.8M | Buy |
+231,900
| New | +$32.8M | 0.02% | 551 |
|